Skip to content

KVP Capital Advisors, LP

Follow

13F filer, CIK 1858198, SAN FRANCISCO, CA

KVP Capital Advisors, LP reported $124,289,546 across 36 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 57.41% of the portfolio.

Accepted , ingested 13F-HR 0001104659-26-127594

Period
2026-09-30
Reported value
$124M
Holdings
36
Top 10 weight
57.41%
New
4
Sold out
3

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SLNnew+684,123$7.48M
VOGXnew+86,069$1.96M
ADILnew+210,256$843K
YARWnew+10,011$225K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
AXSMexited-12,000-$2.94M
SRRKexited-45,000-$2.48M
IRONreduced-14,500-$949K
VYNEexited-500,551-$326K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001104659-26-127594, largest first. % of portfolio is the value over $124,289,546, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 42,900 shares; 2026Q1: 42,900 shares; 2026Q2: 42,900 shares; 2026Q3: 42,900 shares 42,900$12.5M10.05%0Timeline
WHWKWHITEHAWK THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 2,165,997 shares; 2026Q1: 2,165,997 shares; 2026Q2: 2,165,997 shares; 2026Q3: 2,165,997 shares 2,165,997$8.14M6.55%0Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 684,123 shares 684,123$7.48M6.02%newTimeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 53,000 shares; 2026Q1: 53,000 shares; 2026Q2: 53,000 shares; 2026Q3: 53,000 shares 53,000$7.47M6.01%0Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 121,524 shares; 2026Q1: 121,524 shares; 2026Q2: 121,524 shares; 2026Q3: 121,524 shares 121,524$7.12M5.73%0Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 340,000 shares; 2026Q2: 455,000 shares; 2026Q3: 455,000 shares 455,000$6.67M5.37%0Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 414,000 shares; 2026Q1: 414,000 shares; 2026Q2: 414,000 shares; 2026Q3: 414,000 shares 414,000$5.93M4.77%0Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 230,264 shares; 2026Q2: 230,264 shares; 2026Q3: 230,264 shares 230,264$5.75M4.62%0Timeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 133,000 shares; 2026Q1: 133,000 shares; 2026Q2: 133,000 shares; 2026Q3: 133,000 shares 133,000$5.4M4.34%0Timeline
TNDMTANDEM DIABETES CARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 301,000 shares; 2026Q3: 301,000 shares 301,000$4.91M3.95%0Timeline
ACHVACHIEVE LIFE SCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 462,355 shares; 2026Q1: 462,355 shares; 2026Q2: 462,355 shares; 2026Q3: 462,355 shares 462,355$3.74M3.01%0Timeline
STROSUTRO BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 226,575 shares; 2026Q2: 226,575 shares; 2026Q3: 226,575 shares 226,575$3.65M2.94%0Timeline
INSMINSMED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 28,497 shares; 2026Q1: 28,497 shares; 2026Q2: 28,497 shares; 2026Q3: 28,497 shares 28,497$3.25M2.62%0Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 605,280 shares; 2026Q1: 605,280 shares; 2026Q2: 605,280 shares; 2026Q3: 605,280 shares 605,280$3.12M2.51%0Timeline
AVBPARRIVENT BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 102,000 shares; 2026Q3: 102,000 shares 102,000$3.09M2.48%0Timeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 79,700 shares; 2026Q2: 79,700 shares; 2026Q3: 79,700 shares 79,700$3.06M2.46%0Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 58,250 shares; 2026Q1: 58,250 shares; 2026Q2: 58,250 shares; 2026Q3: 43,750 shares 43,750$2.86M2.3%-14,500Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 4,750 shares; 2026Q1: 4,750 shares; 2026Q2: 4,750 shares; 2026Q3: 4,750 shares 4,750$2.57M2.07%0Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 125,000 shares; 2026Q2: 125,000 shares; 2026Q3: 125,000 shares 125,000$2.57M2.07%0Timeline
IMMXIMMIX BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 230,423 shares; 2026Q1: 230,423 shares; 2026Q2: 230,423 shares; 2026Q3: 230,423 shares 230,423$2.4M1.93%0Timeline
DSGNDESIGN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 185,000 shares; 2026Q3: 185,000 shares 185,000$2.33M1.87%0Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 300,000 shares; 2026Q2: 300,000 shares; 2026Q3: 300,000 shares 300,000$2.3M1.85%0Timeline
TVTXTRAVERE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 91,000 shares; 2026Q1: 91,000 shares; 2026Q2: 39,000 shares; 2026Q3: 39,000 shares 39,000$2.3M1.85%0Timeline
MLYSMINERALYS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 84,168 shares; 2026Q3: 84,168 shares 84,168$2.12M1.7%0Timeline
VOGXVOGENX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 86,069 shares 86,069$1.96M1.58%newTimeline
NKTRNEKTAR THERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 26,900 shares; 2026Q1: 26,900 shares; 2026Q2: 26,900 shares; 2026Q3: 26,900 shares 26,900$1.63M1.31%0Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 31,813 shares; 2026Q2: 31,813 shares; 2026Q3: 31,813 shares 31,813$1.58M1.28%0Timeline
ZURAZURA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 373,128 shares; 2026Q2: 373,128 shares; 2026Q3: 373,128 shares 373,128$1.55M1.25%0Timeline
ARTVARTIVA BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 200,000 shares; 2026Q3: 200,000 shares 200,000$1.42M1.15%0Timeline
EOLSEVOLUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 150,000 shares; 2026Q3: 150,000 shares 150,000$1.2M0.97%0Timeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 32,700 shares; 2026Q1: 32,700 shares; 2026Q2: 32,700 shares; 2026Q3: 32,700 shares 32,700$1.06M0.85%0Timeline
CABACABALETTA BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 505,431 shares; 2026Q1: 505,431 shares; 2026Q2: 505,431 shares; 2026Q3: 505,431 shares 505,431$970K0.78%0Timeline
ADILADIAL PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 210,256 shares 210,256$843K0.68%newTimeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 500,000 shares; 2026Q2: 771,000 shares; 2026Q3: 771,000 shares 771,000$802K0.65%0Timeline
CELCCELCUITY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 4,000 shares; 2026Q1: 4,000 shares; 2026Q2: 4,000 shares; 2026Q3: 4,000 shares 4,000$318K0.26%0Timeline
YARWYARROW BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 10,011 shares 10,011$225K0.18%newTimeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
AXSMAXSOME THERAPEUTICS INC.12,000$2.94Mshares
SRRKSCHOLAR ROCK HLDG CORP45,000$2.48Mshares
VYNEVYNE THERAPEUTICS INC500,551$326Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-26-127594 base2026-11-16